Schedule 13D ownership disclosure

Tokai Pharmaceuticals Inc

Security class unavailable · CUSIP: 67011N204

Event date: 2020-12-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000947871-21-000013
Form type
SC 13D/A
Filer
Eledon Pharmaceuticals, Inc.
CIK
CIK 1404281
Filed
Jan 05, 2021
Reporting period
Dec 22, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub